Lovell and Freespira Increase Access to FDA-Cleared, Drug-Free PTSD Treatment for Veterans and Military Personnel
Published: Jun 27, 2023
Freespira's at-home medical device shown to reduce or lead to remission of symptoms associated with panic disorder and PTSD in 28 days, now available to federal healthcare providers.
KIRKLAND, Wash. and PENSACOLA, Fla., June 27, 2023 /PRNewswire/ -- Today, Lovell® Government Services announced a partnership with Freespira, Inc., developer of the leading FDA-cleared medical device for the adjunctive treatment of panic disorder, panic attacks and post-traumatic stress disorder (PTSD) symptoms, to significantly increase treatment access for Veterans struggling with these conditions.
Lovell Government Services will serve as Freespira's Service-Disabled Veteran-Owned Small Business (SDVOSB) vendor, opening up access for Federal healthcare providers to Freespira's drug-free